Diskussionsleiter: H. Bonnemeier (Kiel), M. M. Zylla (Heidelberg)
(P1696) | Gender differences in atrial fibrillation manifestation and risk factors in a population-based cohort – The Gutenberg Health Study | |
S. Skytte Johannsen, P. S. Wild, J. Prochaska, F. Ojeda-Echevarria, T. Zeller, N. Rzayeva, K. J. Lackner, M. E. Beutel, N. Pfeiffer, C. Sinning, T. Münzel, S. Blankenberg, R. Schnabel (Hamburg, Mainz) | ||
(P1697) | Gender Differences in Atrial Fibrillation Risk, the FINRISK Study | |
R. Schnabel, S. Skytte Johannsen, E. Vartiainen, T. Niiranen, S. Blankenberg, F. Ojeda-Echevarria, P. Jousilahti, T. Zeller, K. Kuulasmaa, V. Salomaa (Hamburg; Helsinki, FI) | ||
(P1698) | Bronchopulmonary infections as predictors for cardiac rhythm disturbances – a large real life analysis | |
E. Martens, J. Siebermair, R. Freeden, C. König, M. F. Sinner, S. Veith, S. Kääb (Aichach, München, Meerbusch) | ||
(P1699) | Catheter Ablation of Atrial Fibrillation and Atrial Flutter in Patients with Diabetes Mellitus: Who benefits and who does not? Data from the German Ablation Registry | |
H. Bogossian, L. Eckardt, J. Brachmann, T. Lewalter, E. Hoffmann, K.-H. Kuck, D. Andresen, S. Willems, S. G. Spitzer, T. Deneke, D. Thomas, M. Hochadel, J. Senges, B. Lemke , Deutsches Ablationsregister (Lüdenscheid, Münster, Coburg, München, Hamburg, Berlin, Dresden, Bad Neustadt a. d. Saale, Heidelberg, Ludwigshafen) | ||
(P1700) | Biomarkers of fibrotic turnover and electro-anatomical substrate in AF patients undergoing radiofrequency catheter ablation | |
J. Kornej, P. Büttner, D. Husser-Bollmann, G. Hindricks, A. Bollmann (Leipzig) | ||
(P1701) | Role of endomyocardial biopsies in patients with suspected tachycardiomyopathy | |
A. Kilias, K. Klingel, R. Kandolf, M. Gramlich, J. Schreieck, M. Gawaz, P. Seizer (Tübingen) |